# Enteral Zinc to Improve Growth in Infants at Risk for Bronchopulmonary Dysplasia

> **NCT03532555** · NA · TERMINATED · sponsor: **University of Utah** · enrollment: 37 (actual)

## Conditions studied

- Infant,Premature
- Bronchopulmonary Dysplasia
- Growth Failure

## Interventions

- **DIETARY_SUPPLEMENT:** Zinc Acetate
- **OTHER:** No supplemental zinc

## Key facts

- **NCT ID:** NCT03532555
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-03-22
- **Primary completion:** 2022-05-25
- **Final completion:** 2022-08-25
- **Target enrollment:** 37 (ACTUAL)
- **Why stopped:** Slow enrollment
- **Last updated:** 2023-05-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03532555

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03532555, "Enteral Zinc to Improve Growth in Infants at Risk for Bronchopulmonary Dysplasia". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03532555. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*